By contrast, data from Zhao and Campbell shows that overexpression of endothelial cell growth factors—e.g., VEGF and/or angiopoietin-1—prevented the development of PAH in a monocrotaline-induced rat model [18,87]. The gene discussed is VEGFA; the disease is pulmonary arterial hypertension.